UNICYCIVE THERAPEUTICS, INC. Stock Issued
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Stock Issued of $1.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2025-03-31
- UNICYCIVE THERAPEUTICS, INC. stock issued for the quarter ending 2024-06-30 was -$207.00K, a 134.33% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued for the quarter ending 2024-03-31 was $208.00K, a 8.33% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued for the quarter ending 2023-12-31 was $0.00.
- UNICYCIVE THERAPEUTICS, INC. stock issued for the quarter ending 2023-09-30 was $72.00K.
- UNICYCIVE THERAPEUTICS, INC. stock issued for fiscal 2023 was $867.00K.
- UNICYCIVE THERAPEUTICS, INC. stock issued for fiscal 2020 was $82.00K.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 9 month | Stock Issued 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.00K 10-Q · filed 2024-08-14 | $1.00K derived: sum of 3 quarters · filed 2025-03-31 | $73.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | $208.00K 10-Q · filed 2024-05-13 | $208.00K derived: sum of 2 quarters · filed 2025-03-31 | $280.00K derived: sum of 3 quarters · filed 2025-03-31 | $883.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $72.00K derived: sum of 2 quarters · filed 2025-03-31 | $675.00K derived: sum of 3 quarters · filed 2025-03-31 | $867.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $675.00K derived: sum of 2 quarters · filed 2024-11-13 | $867.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $795.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $192.00K 10-Q · filed 2024-05-13 | |||
| 2021-06-30 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $519.00K 10-Q · filed 2022-08-15 | $551.00K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $72.00K 10-Q · filed 2022-05-12 | $104.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $82.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $50.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |